Aisyah Noor
Stock Analyst at Morgan Stanley
(3.34)
# 2,656
Out of 5,108 analysts
132
Total ratings
57.4%
Success rate
5.2%
Average return
Main Sectors:
Stocks Rated by Aisyah Noor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: TECN Tecan Group AG | Reiterated: Hold | CHF 178.00 → CHF 227.00 | CHF 262.00 | -13.36% | 19 | Nov 5, 2026 | |
| SWX: STMN Straumann Holding AG | Reiterated: Hold | CHF 85.00 → CHF 90.00 | CHF 105.85 | -14.97% | 6 | Oct 19, 2026 | |
| EPA: BIM bioMérieux S.A. | Reiterated: Sell | €64.00 → €66.00 | €94.75 | -30.34% | 10 | Sep 11, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Reiterated: Hold | €60.00 → €71.00 | €80.64 | -11.95% | 17 | Sep 11, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Reiterated: Hold | €25.00 → €22.00 | €27.51 | -20.03% | 5 | Sep 11, 2026 | |
| QGEN Qiagen | Reiterated: Buy | $45 → $47 | $50.86 | -7.64% | 24 | Sep 11, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 270p → 289p | 253p | +14.23% | 5 | Sep 2, 2026 | |
| LON: SN Smith & Nephew plc | Downgraded: Hold | 1,304p → 1,158p | 1,183p | -2.11% | 7 | Sep 2, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €49.00 → €52.00 | €51.87 | +0.25% | 6 | Aug 10, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €32.00 → €31.00 | €42.32 | -26.75% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | CHF 172.00 → CHF 205.00 | CHF 292.20 | -29.84% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €41.00 → €37.00 | €45.00 | -17.78% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 159.00 → CHF 161.00 | CHF 123.20 | n/a | 7 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | kr 182.00 → kr 175.00 | kr 282.50 | n/a | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 22.00 → CHF 20.00 | CHF 16.86 | n/a | 8 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €140.00 → €147.00 | €72.50 | n/a | 2 | Mar 12, 2025 |
Tecan Group AG
Nov 5, 2026
Reiterated: Hold
Price Target: CHF 178.00 → CHF 227.00
Current: CHF 262.00
Upside: -13.36%
Straumann Holding AG
Oct 19, 2026
Reiterated: Hold
Price Target: CHF 85.00 → CHF 90.00
Current: CHF 105.85
Upside: -14.97%
bioMérieux S.A.
Sep 11, 2026
Reiterated: Sell
Price Target: €64.00 → €66.00
Current: €94.75
Upside: -30.34%
DiaSorin S.p.A.
Sep 11, 2026
Reiterated: Hold
Price Target: €60.00 → €71.00
Current: €80.64
Upside: -11.95%
Koninklijke Philips N.V.
Sep 11, 2026
Reiterated: Hold
Price Target: €25.00 → €22.00
Current: €27.51
Upside: -20.03%
Qiagen
Sep 11, 2026
Reiterated: Buy
Price Target: $45 → $47
Current: $50.86
Upside: -7.64%
Convatec Group PLC
Sep 2, 2026
Reiterated: Buy
Price Target: 270p → 289p
Current: 253p
Upside: +14.23%
Smith & Nephew plc
Sep 2, 2026
Downgraded: Hold
Price Target: 1,304p → 1,158p
Current: 1,183p
Upside: -2.11%
Fresenius SE & Co. KGaA
Aug 10, 2026
Reiterated: Buy
Price Target: €49.00 → €52.00
Current: €51.87
Upside: +0.25%
Fresenius Medical Care AG
Aug 5, 2026
Reiterated: Sell
Price Target: €32.00 → €31.00
Current: €42.32
Upside: -26.75%
Jun 23, 2026
Upgraded: Hold
Price Target: CHF 172.00 → CHF 205.00
Current: CHF 292.20
Upside: -29.84%
Jun 23, 2026
Reiterated: Hold
Price Target: €41.00 → €37.00
Current: €45.00
Upside: -17.78%
Sep 9, 2025
Reiterated: Buy
Price Target: CHF 159.00 → CHF 161.00
Current: CHF 123.20
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: kr 182.00 → kr 175.00
Current: kr 282.50
Upside: n/a
Mar 18, 2025
Reiterated: Hold
Price Target: CHF 22.00 → CHF 20.00
Current: CHF 16.86
Upside: n/a
Mar 12, 2025
Reiterated: Hold
Price Target: €140.00 → €147.00
Current: €72.50
Upside: n/a